Expression of tissue factor pathway inhibitor by endothelial cells and platelets
Authors:
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 38 (1) , 9-14
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A GPI‐anchored co‐receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expressionJournal of Thrombosis and Haemostasis, 2006
- Interactions of Platelets, Blood‐Borne Tissue Factor, and Fibrin During Arteriolar Thrombus Formation In VivoMicrocirculation, 2005
- The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has just begunJournal of Thrombosis and Haemostasis, 2005
- Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic reviewThrombosis and Haemostasis, 2005
- Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and strokeThrombosis and Haemostasis, 2004
- Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary SyndromesCirculation, 2003
- Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisBlood, 2003
- Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2001
- Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VIIClinical Science, 2001
- Blocking of tissue factor pathway inhibitor (TFPl) shortens the bleeding time in rabbits with antibody induced haemophilia ABlood Coagulation & Fibrinolysis, 1995